Biblio

Found 17 results
Filters: Keyword is Disease Progression  [Clear All Filters]
2014
T. A. Winstone, Assayag, D., Wilcox, P. G., Dunne, J. V., Hague, C. J., Leipsic, J., Collard, H. R., and Ryerson, C. J., “Predictors of mortality and progression in scleroderma-associated interstitial lung disease: a systematic review.”, Chest, vol. 146, no. 2, pp. 422-36, 2014.
P. G. Woodruff, Chatila, W., Connett, J. E., Criner, G. J., Curtis, J. L., Dransfield, M. T., Han, M. L. K., Lazarus, S. C., Marchetti, N., Rogers, T. J., Scanlon, P. D., Sin, D. D., Voelker, H., Wendt, C., and Albert, R. K., “Tumour necrosis factor receptor-75 and risk of COPD exacerbation in the azithromycin trial.”, Eur Respir J, vol. 43, no. 1, pp. 295-8, 2014.
2013
H. Yun Park, Churg, A., Wright, J. L., Li, Y., Tam, S., Man, S. F. Paul, Tashkin, D., Wise, R. A., Connett, J. E., and Sin, D. D., “Club cell protein 16 and disease progression in chronic obstructive pulmonary disease.”, Am J Respir Crit Care Med, vol. 188, no. 12, pp. 1413-9, 2013.
H. O. Coxson, Dirksen, A., Edwards, L. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. Ma, Celli, B., Crim, C., Duvoix, A., Fauerbach, P. Nasute, Lomas, D. A., MacNee, W., Mayer, R. J., Miller, B. E., Müller, N. L., Rennard, S. I., Silverman, E. K., Tal-Singer, R., Wouters, E. Fm, and Vestbo, J., “The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.”, Lancet Respir Med, vol. 1, no. 2, pp. 129-36, 2013.
C. J. Ryerson, Urbania, T. H., Richeldi, L., Mooney, J. J., Lee, J. S., Jones, K. D., Elicker, B. M., Koth, L. L., King, T. E., Wolters, P. J., and Collard, H. R., “Prevalence and prognosis of unclassifiable interstitial lung disease.”, Eur Respir J, vol. 42, no. 3, pp. 750-7, 2013.
H. Yun Park, Man, S. F. Paul, Tashkin, D., Wise, R. A., Connett, J. E., Anthonisen, N. A., and Sin, D. D., “The relation of serum myeloperoxidase to disease progression and mortality in patients with chronic obstructive pulmonary disease (COPD).”, PLoS One, vol. 8, no. 4, p. e61315, 2013.
A. Hakimi Shoki, Mayer-Hamblett, N., Wilcox, P. G., Sin, D. D., and Quon, B. S., “Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations.”, Chest, vol. 144, no. 5, pp. 1659-70, 2013.
J. A. Russell, Fjell, C., Hsu, J. L., Lee, T., Boyd, J., Thair, S., Singer, J., Patterson, A. J., and Walley, K. R., “Vasopressin compared with norepinephrine augments the decline of plasma cytokine levels in septic shock.”, Am J Respir Crit Care Med, vol. 188, no. 3, pp. 356-64, 2013.
2012
D. W Reid, Yamabayashi, C., Goodridge, D., Chung, F., Hunt, M. A., Marciniuk, D. D., Brooks, D., Chen, Y. - W., Hoens, A. M., and Camp, P. G., “Exercise prescription for hospitalized people with chronic obstructive pulmonary disease and comorbidities: a synthesis of systematic reviews.”, Int J Chron Obstruct Pulmon Dis, vol. 7, pp. 297-320, 2012.
A. Hendel, Cooper, D., Abraham, T., Zhao, H., Allard, M. F., and Granville, D. J., “Proteinase inhibitor 9 is reduced in human atherosclerotic lesion development.”, Cardiovasc Pathol, vol. 21, no. 1, pp. 28-38, 2012.
S. Van Eeden, Leipsic, J., Man, S. F. Paul, and Sin, D. D., “The relationship between lung inflammation and cardiovascular disease.”, Am J Respir Crit Care Med, vol. 186, no. 1, pp. 11-6, 2012.
2011
J. Vestbo, Edwards, L. D., Scanlon, P. D., Yates, J. C., Agusti, A., Bakke, P., Calverley, P. M. A., Celli, B., Coxson, H. O., Crim, C., Lomas, D. A., MacNee, W., Miller, B. E., Silverman, E. K., Tal-Singer, R., Wouters, E., and Rennard, S. I., “Changes in forced expiratory volume in 1 second over time in COPD.”, N Engl J Med, vol. 365, no. 13, pp. 1184-92, 2011.
C. J. Ryerson, Abbritti, M., Ley, B., Elicker, B. M., Jones, K. D., and Collard, H. R., “Cough predicts prognosis in idiopathic pulmonary fibrosis.”, Respirology, vol. 16, no. 6, pp. 969-75, 2011.
S. H. Ling, McDonough, J. E., Gosselink, J. V., W Elliott, M., Hayashi, S., Hogg, J. C., and van Eeden, S. F., “Patterns of retention of particulate matter in lung tissues of patients with COPD: potential role in disease progression.”, Chest, vol. 140, no. 6, pp. 1540-9, 2011.
H. A. Gietema, Müller, N. L., Fauerbach, P. V. Nasute, Sharma, S., Edwards, L. D., Camp, P. G., and Coxson, H. O., “Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort.”, Acad Radiol, vol. 18, no. 6, pp. 661-71, 2011.
2004
J. C. Hogg, Chu, F., Utokaparch, S., Woods, R., W Elliott, M., Buzatu, L., Cherniack, R. M., Rogers, R. M., Sciurba, F. C., Coxson, H. O., and Paré, P. D., “The nature of small-airway obstruction in chronic obstructive pulmonary disease.”, N Engl J Med, vol. 350, no. 26, pp. 2645-53, 2004.
2002
T. Suwa, Hogg, J. C., Quinlan, K. B., Ohgami, A., Vincent, R., and van Eeden, S. F., “Particulate air pollution induces progression of atherosclerosis.”, J Am Coll Cardiol, vol. 39, no. 6, pp. 935-42, 2002.